Curriculum Vitae

PERSONAL DETAILS
ADMINISTRATIVE DUTIES
(Role),(Level),(Duration)
  • Deputy Director, Medical Advancement for Better Quality of Life Impact Lab, 01/09/2022 to present
  • Member of Faculty Research Committee, Faculty of Health and Medical Sciences, Taylor s University, 01/12/2019 to present
  • Senior Lecturer, Faculty of Health & Medical Sciences, 01/08/2017 to present
  • Programme Director - Bachelor of Biomedical Science (Hons), School of Biosciences, Faculty of Health and Medical Sciences, Taylor s University, 01/01/2024 to present
  • Editor , Malaysian Journal of Biochemistry and Molecular Biology (MJBMB), 01/02/2023 to present
  • Member of Centre for Drug Discovery and Molecular Pharmacology (CDDMP), Faculty of Health and Medical Sciences, Taylor's University, 01/01/2021 to 31/12/2022
  • Advisor of Taylor's University School of Biosciences (TUSOB), School of Biosciences, Faculty of Health and Medical Sciences, Taylor s University, 27/08/2018 to 09/08/2021
ACADEMIC QUALIFICATION
(Qualification),(Institution)
  • Doctor of Philosophy (Cell Biology), UNIVERSITI MALAYA, Malaysia
  • Bachelor of Science (Hons) - Biomedical Science, UNIVERSITI TUNKU ABDUL RAHMAN, Malaysia
PROFESSIONAL MEMBERSHIP
(Organisation),(Role),(Duration),(Level)
  • MALAYSIAN ALLIED HEALTH PROFESSIONS COUNCIL, Professional Member, Since 2024 (National)
  • Persatuan Sains Bioperubatan Malaysia (MyBiomed), Executive Committee Member, Since 2024 (National)
  • Sigma Xi, The Scientific Research Honor Society, Member, 2023 to 2024 (International)
  • Malaysian Society of Bioinformatics and Computational Biology (MaSBiC), Member, 2023 to present (National)
  • Young Scientists Network - Academy of Sciences Malaysia (YSN-ASM), Fellow Member, 2022 to present (National)
  • European Society for Medical Oncology (ESMO), Member, 2020 to 2023 (International)
  • European Vascular Biology Organization (EVBO), Member, 2019 to 2022 (International)
  • Royal Society of Biology, Member, 2018 to 2023 (International)
  • European Society of Gene and Cell Therapy, Academic Member, 2018 to 2019 (International)
  • MALAYSIAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, Executive Committee Member, 2017 to 2023 (National)
  • European Society of Cardiology Member, Member, 2016 to 2017 (International)
  • European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Member, 2015 to 2020 (International)
AREAS OF EXPERTISE
(Area)
  • Nano Particle (Cancer Theragnostics (Gold nanoparticles, nanocurcumins))
  • Regenerative Medicine (Stem cells)
  • Medical Pharmacology (Natural products (plant, herbs, venomics))
  • Cardiology (Angiogenesis, cardiac regeneration)
  • Virology (Dengue, EV71)
  • Traditional Medicine And Natural Products
RESEARCH INTEREST
(Research Area)
  • Genome editing abrogates tumorigenesis and angiogenesis
  • Stem cells applications in regenerative medicine, disease modelling and drug discovery
  • Discovery and development of peptide-based medicine in human (diabetes, heart diseases and cancer) and infectious diseases .
TEACHING
(Course Title),(Level of Study),(Institution),(Month/Year)
  • Applications of Bioinformatics, Bachelor Degree, Taylor's University (03/2020)
  • Clinical Genetics, Bachelor Degree, Taylor's University (03/2019)
  • Cell Biology, Bachelor Degree, Taylor's University (03/2018)
  • Eukaryotic Cell Biology, Bachelor Degree, Taylor's University (03/2018)
  • Human Pathology, Bachelor Degree, Taylor's University (03/2018)
  • Instrumentation in Medical Diagnostic, Laboratory Science and Blood Banking, Bachelor Degree, Taylor's University (08/2018)
  • Principles of Drug Discovery and Development, Bachelor Degree, Taylor's University (08/2017)
  • Human Molecular Genetics, Bachelor Degree, Taylor's University (08/2017)
  • Genes and Tissue Culture Technology, Bachelor Degree, Taylor's University (08/2017)
PUBLICATIONS
(Title of publication in APA style)
Book Chapter
2011
  • Tang, YQ., Sekaran, SD.. (2011). Prostate Cancer-From Bench to Bedside. By Dr. Philippe E. Spiess (Ed.), In Intech, Evaluation of Phyllanthus, for Its Anti-Cancer Properties (pp. ).
Article in Journals
2024
  • Law, G. Y., Chong, L. C. and Tang, Y. Q. (2024). Antihypertensive effects of condiments prepared from fermented legumes: A review. 31(1). https://doi.org/10.47836/ifrj.31.1.01 (ISI-Indexed)
     
  • Lim, MW, Tang, YQ, Aroua, MK, Gew, LT. (2024). Glycerol extraction of bioactive compounds from Thanaka (Hesperethusa crenulate) Bark through LC-MS profiling and their antioxidant properties. ACS Omega (Accepted)
2023
  • Abbas, N., Tan, H.D., Gog, B.H., Yap, W.H., Tang, Y.Q. (2023). In-Silico Study of Anticancer and Antimicrobial Peptides Derived from Cycloviolacin O2 (CyO2). Biointerface Research in Applied Chemistry. (Accepted) (ISI-Indexed)
     
  • Lim, J.Y., Gew, L.T., Tang, Y.Q. (2023). Biocomputational-mediated screening and molecular docking platforms for discovery of coumarin-derived antimelanogenesis agents. Dermatologica Sinica.4(1), 8-17. (ISI-Indexed)
     
  • Tan Hao Dong, Ashlyn Yau Wen Ning & Tang Yin Quan (2023) Network pharmacology-integrated molecular docking analysis of phytocompounds of Caesalpinia pulcherrima (peacock flower) as potential anti-metastatic agents, Journal of Biomolecular Structure and Dynamics, DOI: 10.1080/07391102.2023.2202273 (ISI-Indexed)
  • Law, G.Y., Chong, L.C., Tang, Y.Q., Yan, S.W. (2023). Physicochemical properties and consumer acceptance of sodium-reduced condiment from fermented horse gram (Macrotyloma uniflorum), International Journal of Gastronomy and Food Science. 32, 100730.https://doi.org/10.1016/j.ijgfs.2023.100730. (ISI-Indexed)
     
  • Chun, C. Y., Khor, S. X. Y., Chia, A. Y. Y., & Tang, Y. Q. (2023). In silico study of potential SARS-CoV-2 antagonist from Clitoria Ternatea. International Journal of Health Sciences, 17(3), 3–10. Retrieved from https://ijhs.qu.edu.sa/index.php/journal/article/view/7719 (ISI-Indexed)
     
  • Phoebe Tee Yon Ern, Tang Yin Quan, Fung Shin Yee & Adeline Chia Yoke Yin (2023) Therapeutic properties of Inonotus obliquus (Chaga mushroom): a review, Mycology, DOI: 10.1080/21501203.2023.2260408 (ISI-Indexed)
     
2022
  • Vellasamy, D.M.; Lee, S.-J.; Goh, K.W.; Goh, B.-H.; Tang, Y.-Q.; Ming, L.C.; Yap, W.H. Targeting Immune Senescence in Atherosclerosis. Int. J. Mol. Sci. 2022, 23, 13059. https://doi.org/10.3390/ijms232113059 (ISI-Indexed)
     
  • Tan, H.D., Leong, H.J.Y., Yap, W.H., Chia, A.Y.Y., Tang, Y-Q. (2023). Network Analysis in the Identification of Genes Conferring Metastatic Potential in Hepatocellular Carcinoma. Eurasian Journal of Medicine and Oncology. (Accepted) (ISI-Indexed)
     
  • Fauzi, A., Chia, A.Y.Y, Tang Y.Q. (2022). Current Diabetes Technology and its Challenges. Turkish Journal of Endocrinology and Metabolism. 26: 38-47 (ISI-Indexed)
     
  • Yow, H-Y., Tang, Y-Q., Lee, J-S. (2022). Antiproliferation effect of aspirin and diclofenac on MDA-MD-231 triple-negative breast cancer cells. Malaysian Journal of Biochemistry & Molecular Biology. 25(1), 88-92. (SCOPUS-Indexed)
     
  • Siew, W.S., Tang, Y.Q., Yap, W.H. (2022). Integrated Assessment of Macrophage Lipids Homeostasis Omics Data: Identification of Potential Genes and Pathways in Atherosclerosis. Progress in Drug Discovery & Biomedical Science. 5(1). https://doi.org/10.36877/pddbs.a0000304 (SCOPUS-Indexed)
     
  • Tang, Y.Q., Chia, A.Y.Y., Yap, W.H. (2022). 246P DNA repair protein RAD51 homolog 1 (RAD51), a potential prognostic biomarker and target for breast cancer. Annals of Oncology. 33(3): S235-S236. (ISI-Indexed)
  • Mahendra, C.K., Ser, H.L., Pusparajah, P., Htar, T.T., Chuah, L.H., Yap, W.H., Tang, Y.Q., Zengin, G., Tang, S.Y., Lee, W.L., Liew, K.B., Ming, L.C., Goh, B.H. (2022). Cosmeceutical Therapy: Engaging the Repercussions of UVR Photoaging on the Skin’s Circadian Rhythm. International Journal of Molecular Sciences. 23(5):2884. https://doi.org/10.3390/ijms23052884 (ISI-Indexed)
     
  • Ooi YY, Chia AYY, Teoh ML, Lee SH, Tang YQ, Chua LL, Looi CY, Ng WK, Tor YS, Yong PVC. (2022). Redesigning Biomedical Science Practicum towards a New Frontier, International Journal of Information and Education Technology, DOI: 10.18178/IJIET (SCOPUS-Indexed)
  • Yow, H.Y., Tang, Y.Q. 2022. Computational screening of repurposed drugs targeting SARS-COV-2 main protease by molecular docking. Sudan Journal of Medical Sciences (Accepted) (ISI-Indexed)
     
2021
  • Chan G.C.K., Rave T., Yan S.W., Chia A.Y.Y., Yap W.H. and Tang Y.Q. . (2021). Biological Properties of Stigmasterol and other Phytosterols. Malaysian Journal of Biochemistry & Molecular Biology (MJBMB). 1, 52 - 64. (SCOPUS-Indexed)
     
  • Y.Q. Tang & T.N. Soon (2021). Investigation of scorpion venom-derived anticancer peptides inhibition of metastatic cancer cells growth and induction of apoptosis. Ann Oncol . 32, S1. (ISI-Indexed)
  • Manap AS, Lum YK, Ong LH, Tang YQ, Gew LT, Chia AY. Perspective approaches on melanogenesis inhibition. Dermatol Sin 2021. 39(1),1-12 (ISI-Indexed)
     
  • Tsuey Ning Soon, Wei Hsum Yap, Ya Chee Lim, Chiau Ming Long, Bey Hing Goh* and Yin-Quan Tang*. (2021). “Prospects of antiviral drugs derived from natural products: Targeting SARS-CoV entry and replication”, Current Traditional Medicine (2021) 7: 1. (ISI-Indexed)
     
  • Ewen ST, Fauzi A, Quan TY, Chamyuang S, Yin ACY. (2021) A review on advances of treatment modalities for Alzheimer's disease. Life Sci. Jan 27:119129. doi: 10.1016/j.lfs.2021.119129. Epub ahead of print. PMID: 33515559.
     
  • Siew, W.S.; Tang, Y.Q.; Kong, C.K.; Goh, B.-H.; Zacchigna, S.; Dua, K.; Chellappan, D.K.; Duangjai, A.; Saokaew, S.; Phisalprapa, P.; Yap, W.H. Harnessing the Potential of CRISPR/Cas in Atherosclerosis: Disease Modeling and Therapeutic Applications. Int. J. Mol. Sci. 2021, 22, 8422. https://doi.org/10.3390/ijms22168422 (ISI-Indexed)
     
  • Yap WH, Teoh ML,Tang YQ, Goh B-H. Exploring the use of virtual laboratory simulations before, during, and postCOVID-19 recovery phase: An Animal Biotechnology case study. Biochem Mol Biol Educ.2021;1–7. (ISI-Indexed)
     
  • Subermaniam K, Teoh SL, Yow YY, Tang YQ, Lim LW, Wong KH. Marine algae as emerging therapeutic alternatives for depression: A review. Iran J Basic Med Sci 2021; 24:1-17.
     
2020
  • Soon, T.N, Chia, A.Y.Y, Yap W.H. and Tang Y-Q. (2020). Animal Venom-derived Antimicrobial Peptides: Novel AND Improved Weapon for Cancer Treatment. Malaysian Journal of Biochemistry & Molecular Biology. 1, 1 - 9. (SCOPUS-Indexed)
     
  • Soon, T.N., Chia, A.Y.Y., Yap, W.H., Tang Y.Q. (2020). Anticancer Mechanisms of Bioactive Peptides. Protein & Peptide Letters. 27: 1-8 (ISI-Indexed)
     
  • Ng SL, Soon TN, Yap WH, Liew KB, Lim YC, Ming LC, et al. (2020). Convalescent plasma: A potential therapeutic option for COVID-19 patients. Asian Pac J Trop Med. 13(11): 477-486. (ISI-Indexed)
     
  • Ong CP, Lee WL, Tang YQ, Yap WH. Honokiol: A Review of Its Anticancer Potential and Mechanisms. Cancers 2020, 12, 48. (ISI-Indexed)
     
2019
  • Tang, Y-Q, Yap, W.H. and Chia, A.Y.Y. (2019). Identification of Scorpion Venom-Derived Peptides Inhibiting Vascular Endothelial Growth Factor (VEGF)-Mediated Angiogenesis. 56, 106-107. (ISI-Indexed)
2018
  • T.Kocijana, A.Cappelletto, M.Rehmana, Y.Q.Tang, S.Vodreta, L.Zentilin, M.Giacca and S.Zacchigna. (2018). “Understanding the poor angiogenic capacity of the mammalian heart.” Vascular Pharmacology, 103: 58-59. (ISI-Indexed)
2017
  • Cappelletto, A.A., Tang, Y-Q., Rehman, M., Pierro, C., Zacchigna, S. (2017). Understanding the poor angiogenic capacity of the mammalian heart. European Journal of Heart Failure. 19: 339-340. (ISI-Indexed)
2016
  • Tang, Y. Q., Cappelletto, A., Zacchigna, S. (2016). The angiogenic potential of the mammalian heart is halted soon after birth. Human Gene Therapy. 27 (11): A101-A101. (ISI-Indexed)
  • Yap, MS., Tang, YQ., Yeo, Y., Lim, WL., Lim, LW., Tang, KO., Richards, M., Othman, I., Poh, CL., Heng, BC. (2016). Pluripotent Human embryonic stem cell derived neural lineages for in vitro modelling of enterovirus 71 infection and therapy. Virology Journal. 13 (5). (ISI-Indexed)
2015
  • Tang, YQ., Jaganath, IB, Manikam, R., Sekaran, SD. (2015). Phyllanthus spp. Exerts Anti-Angiogenic and Anti-Metastatic Effects through Inhibition on Matrix Metalloproteinase Enzymes. Nutrition and Cancer. 67(5): 783-795. (ISI-Indexed)
2014
  • Tang, YQ., Jaganath, IB., Manikam, R., Sekaran, SD. (2014). Inhibition of MAPKs, Myc/Max, NFκB, and Hypoxia pathways by Phyllanthus prevents proliferation, metastasis and angiogenesis in human melanoma (MeWo) cancer cell line . International Journal of Medical Sciences. 11(6):564-577. (ISI-Indexed)
  • Tang YQ., Lee SH., Sekaran SD. (2014). Phyllanthus sp a Local Plant with Multiple Medicinal Properties. JUMMEC. 17 (2)
2013
  • Tang, YQ., Jaganath, IB., Manikam, R., Sekaran, SD. (2013). Phyllanthus suppresses Prostate Cancer Cell, PC-3 Proliferation and Induces Apoptosis through Multiple Signalling Pathways (MAPKs, PI3K/Akt, NFκB and Hypoxia). Evidence-Based Complementary and Alternative Medicine 13: doi:10.1155/2013/609581. (ISI-Indexed)
  • Lee, SH., Tang, YQ., Rathakrishnan, A., Wang, SM., Ong, KC., Manikam, R., Payne, BJ., Jaganath, IB., Sekaran, SD. (2013). Effect of a Local Malaysian Medicinal Plant (Phyllanthus) against Dengue Virus 2. BMC Complementary and Alternative Medicine 13: doi:10.1186/1472-6882-13-192. (ISI-Indexed)
2010
  • Tang, YQ., Jaganath, IB., Sekaran, SD. (2010). Phyllanthus spp. Induces Selective Growth Inhibition of PC-3 and MeWo Human Cancer Cells through Modulation of Cell Cycle and Induction of Apoptosis. PLoS ONE 5(9): e12644. doi:10.1371/journal.pone.0012644. (ISI-Indexed)
Article in Proceeding
2019
  • Yap, W.H., Teoh M.L., Tang Y-Q. (2019). Transforming assessment design and recognition of competency-based skill sets in biosciences graduates. Proceedings of the 1st International e-Learning Carnival and Conference 2019 (eLCC 2019) 26th June 2019, UTeM, Melaka
RESEARCH PROJECT
(Project title),(Role),(Duration),(Level)
  • Profiling human salivary biomarker(s) panel as a non-invasive detection method for myocardial infarction (MI), Co-researcher, 2023 to 2025 (Taylor's University)
  • Identification and evaluation of diagnostic tumour-homing peptides specifically targeting metastatic breast cancer cells using phage-displayed peptide libraries, Project Leader, 2020 to 2024 (National)
  • Glycerol as a sustainable solvent in the extraction of bioactive compounds from Thanaka bark as natural sunscreens, Co-researcher, 2020 to 2022 (National)
  • A novel approach of using mRNAs transcription factor in reprogramming human mesenchymal stem cells into insulin producing cells, Co-researcher, 2019 to 2023 (National)
  • A Novel Approach towards Public Health Salt Reduction Strategy Using Legume-Based Nutritionally Enhanced Reduced Sodium Seasoning with Potential Therapeutic Properties, Co-researcher, 2019 to 2023 (National)
  • Unraveling the role of cellular senescence marker p16INK4a in atherosclerotic lesion fatty streaks foam cells formation, Co-researcher, 2019 to 2023 (National)
  • In silico prediction and in vitro validation of mauriporin-derived peptides as potential therapeutic anticancer agents, Project Leader, 2018 to 2019 (Taylor's University)
  • The role of Glycyrrhizic acid and glabridin on pigmentation as anti-melanogenesis in aging, Co-researcher, 2018 to 2020 (Taylor's University)
  • Investigating the Modulatory Effects of Swietenia Macrophylla Seed Extracts and Limonoid Compounds in Regulating Macrophage Cholesterol Homeostasis , Co-researcher, 2018 to 2020 (Taylor's University)
  • Investigating the modulatory effects of Swietenia Macrophylla seed extracts and limonoid compounds in regulating macrophage cholesterol homeostasis , Co-researcher, 2018 to 2019 (Taylor's University)
EVALUATION ACTIVITIES
(Activity),(Duration),(Category)
  • As an editor member of International Journal of Neuroinformatics, my job description are as follows: 1. Chooses the philosophical direction of the publication. 2. Screening of manuscripts submitted for possible publication 3. Determine whether article to be accepted or rejected, 2018 to 2022 (Article in Journal)
  • Undergraduate ("Biomedical Science", "Biotechnology" and "Food science and Nutrition) Honors theses, 2017 to 2017 (Thesis)
  • Manuscript reviewer for Scientific Reports - Nature (Manuscript number: SREP-16-00746-T), 2016 to 2016 (Article in Journal)
SUPERVISION
(Title of Thesis),(Name of Candidates),(Academic Level),(Role)
ONGOING
  • Lum Yin Kei, Master by Research  (Co-supervisor (External))
  • Lim Min Wen, Master by Research  (Co-supervisor (External))
  • Pornnatcha Tidchob, Master by Research  (Co-supervisor (External))
  • Kanjana Soodpakdee, Master by Research  (Co-supervisor (External))
  • AYESHA SHAHIRA BINTI MOHD FAUZI  (Co-supervisor (Internal))
  • SIEW WEI SHENG  (Co-supervisor (Internal))
  • LAW GAR YI  (Co-supervisor (Internal))
  • DHAYAALINI A/P BALA GOPAL  (Main Supervisor)
  • SABRINA KHOR XIN YI  (Main Supervisor)
COMPLETED
  • IN SILICO PREDICTION AND IN VITRO VALIDATION OF MAURIPORIN-DERIVED PEPTIDES AS POTENTIAL ANTICANCER THERAPEUTIC AGENT, SOON TSUEY NING  (Main Supervisor)
  • IN SILICO PREDICTION AND IN VITRO EVALUATION OF CORDYCEPS MILITARIS-DERIVED NUCLEOSIDES AS POTENTIAL THERAPEUTIC AGENT AGAINST ALZHEIMER'S DISEASE, SE THOE EWEN  (Co-supervisor (Internal))
  • Anticancer activity of Hybrid Peptide, RetroMad1 against cancer cells, Vyvian Lee Yee Ting, Bachelor s degree  (Main Supervisor)
  • Anticancer properties of human salivary-derived peptides targeting MCF-7 breast cancer cells, Gloria Ng Hui Ying, Bachelor s degree  (Main Supervisor)
  • Discovery and development of potent and non-toxic anticancer peptides from Scorpion Venom, Kirubhan Nadarajan, Bachelor s degree  (Main Supervisor)
  • The role of Glycyrrhizic acid and glabridin on pigmentation as anti-melanogenesis in aging , Kai Yan Cheng , Bachelor s degree  (Co-supervisor (Internal))
  • Evaluation of the use of therapeutic peptides to target and kill cancer cells, Julia Harju, Bachelor s degree  (Main Supervisor)
  • Investigation of anti-cancer activity of hybrid peptide on lung cancer cells , TARINI A/P VEERAPPAN , Bachelor s degree  (Main Supervisor)
  • Investigation of the correlation between antioxidant and anticancer properties of Forsythia Suspensa, Ligustrum lucidum and Lycium chinense fruit water plant extract on breast cancer cell line, MANOSHA A/P RAGUNATHAN , Bachelor s degree  (Main Supervisor)
  • Evaluation of anticancer and antimicrobial activities of natural compounds , Tanish Rave, Bachelor s degree  (Main Supervisor)
  • SYNTHESIZATION AND CHARACTERIZATION OF GREEN BIOSYNTHESIS NANOCURCUMIN, Jesvinder Jeet Kaur A/P Baldev Singh, Bachelor s degree  (Main Supervisor)
  • GREEN BIOSYNTHESIS OF GOLD NANOPARTICLES USING GREEN TEA EXTRACT FROM DIFFERENT BRANDS AND CHARACTERIZATION OF THE GOLD NANOPARTICLES AND THEIR ANTIBACTERIAL PROPERTIES, Mong Jia Ai, Bachelor s degree  (Main Supervisor)
  • The anticancer properties of GA and Glabridin on melanoma cells , Jessica Heasman , Bachelor s degree  (Co-supervisor (Internal))
  • The antiproliferative activity of cordyceps on HaCaT and fibroblast cells, Ewan Camplisson , Bachelor s degree  (Main Supervisor)
  • The antimelanogenesis activity of cordyceps on melanoma cells , Amber Hardy , Bachelor s degree  (Main Supervisor)
PRESENTATION
(Title),(Event),(Date Presented),(Organiser),(Level)
ORAL PRESENTER
  • Identification, Characterization and Validation of Potential Therapeutic Scorpion Venom-derived Peptides with Dual Anticancer and Antimicrobial Activities , The 14th Asian Congress in Biotechnology , 01/07/2019 to 04/07/2020, Asian Federation of Biotechnology (AFOB) and Biotechnology and Biochemical Engineering Society of Taiwan (BEST)  (International)
  • Transforming assessment design and recognition of competency-based skill sets in biosciences graduates, 1st International e-Learning Carnival and Conference 2019 (eLCC 2019), 26/06/2019 (International)
  • Identification of Scorpion Venom-Derived Peptides Inhibiting Vascular Endothelial Growth Factor (VEGF)-Mediated Angiogenesis, ESM-EVBO MEETING 2019, 15/04/2019 (International)
  • In Silico Identification and Biological Evaluation of Anticancer Peptides Derived from Scorpion Venom, ASEAN Emerging Researchers Conference 2018, 03/12/2018 to 04/12/2018, Sunway University and University of Cambridge (International)
  • Understanding the poor angiogenic capacity of the heart, 21st ICGEB Annual Symposium, 14/06/2016 to 15/06/2016, International Centre for Genetic Engineering and Biotechnology (International)
POSTER PRESENTER
  • Investigation of scorpion venom-derived anticancer peptides inhibition of metastatic cancer cells growth and induction of apoptosis., ESMO Targeted Anticancer Therapies Virtual Congress 2021 (ESMO TAT 2021), 01/03/2021 to 02/03/2021, European Society for Medical Oncology (International)
  • In silico design of biologically active anticancer peptides derived from Royal Jelly,Royalisin, MSBMB-Taylor's Virtual Focused Meeting 2020, 19/11/2020 to 19/11/2020, Malaysian Society for Biochemistry and Molecular Biology (MSBMB) and Taylor s University Faculty of Health and Medical Sciences (Malaysia) (International)
  • Scorpion Venom-derived Therapeutic Peptides Inhibiting Vascular Endothelial Growth Factor (VEGF)-mediated Angiogenesis, KSBMB International Conference 2019, 02/06/2019 to 05/06/2019, Korean Society for Biochemistry and Molecular. Biology (KSBMB) (International)
  • IDENTIFICATION OF POTENTIAL THERAPEUTIC SCORPION VENOM-DERIVED PEPTIDES WITH ANTIANGIOGENIC AND ANTIMETASTATIC ACTIVITIES, National Oncology Pharmacy Conference 2019 (NOPC2.0), 09/04/2019 to 11/04/2019, Institut Kanser Negara (National)
  • IN SILICO INVESTIGATION of FUNCTIONAL SCORPION VENOM DERIVED PEPTIDES TARGETING CANCER CELLS, 2018 IUBMB SEOUL, 04/06/2018 to 08/06/2018, International Union of Biochemistry and Molecular Biology (IUBMB) Federation of Asian and Oceanian Biochemists and Molecular Biologists (FAOBMB) Korean Society for Biochemistry and Molecular Biology (KSBMB) (International)
  • The angiogenic potential of mammalian heart is halted soon after birth, ESGCT and ISSCR Congress, 17/10/2016 to 22/10/2016, European Society of Gene & Cell Therapy (International)
  • Phyllanthus suppresses prostate (PC-3) and melanoma (MeWO) cancers proliferation and induces apoptosis through multiple signalling pathways, 25th European Congress of Clinical Microbiology and Infectious Diseases, 25/04/2015 to 28/04/2015, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) (International)
  • The anticancer properties of Malaysia local medicinal plant, Phyllanthus against melanoma and prostate cancer cells, International Research Symposium on Population Health, Malaysia, 19/11/2013 to 20/11/2013, Centre for Population Health, Faculty of Medicine, University of Malaya (International)
  • Effects of Potential of Malaysian Medicinal Plant (Phyllanthus) Against Dengue Virus Type 2 (DENV2), 9th Asia-Pacific Congress Medical Virology (APCMV), 06/06/2012 to 08/06/2012, Australian Society for Microbiology (International)
  • The anti-metastatic and anti-angiogenesis properties of Phyllanthus species, 18th International Student Congress of (Bio)Medical Sciences (ISCOMS), 07/06/2011 to 10/06/2011, International Student Congress of (Bio)Medical Sciences (ISCOMS) (International)
  • Potential Anticancer Properties of Phyllanthus Against Skin Melanoma and Prostate Cancer Cells, Creativity and Innovation Expo University of Malaya 2010, 01/04/2010 to 03/04/2010, University of Malaya (National)
  • Anticarcinogenic properties of extracts derived from medicinal plant, Phyllanthus on human skin and prostate cancer cells, UK-Malaysia Symposia of Cancer Drug Discovery and Development, 24/02/2010 to 25/02/2010, Cancer Research Initiatives Foundation (Carif) (International)
OTHERS
  • Understanding the poor angiogenic capacity of mammalian heart, Myocardial Function & Cellular Biology of the Heart Meeting 2017, 25/05/2017 to 28/11/2017, ESC of "Myocardial Function" and "Cellular Biology of the Heart" (International)
  • Understanding the poor angiogenic capacity of mammalian heart, HFA Winter Meeting on Translational Heart Failure Research, 25/01/2017 to 28/01/2017, Heart Failure Association of the ESC (HFA)  (International)
  • The poor angiogenic potential of mammalian adult heart, Joint International Meeting Perspectives in Vascular Biology, 26/09/2016 to 28/09/2016, "German Society for Microcirculation and Vascular Biology" & "Endothelial Signalling and Vascular Repair" (International)
  • Early differential changes in microvascular barrier function in response to Dengue virus, 45th Parasitological Society of Southern Africa (PARSA) Conference, 28/08/2016 to 31/08/2016, Parasitological Society of Southern Africa  (International)
  • Microvascular Endothelial Cells Responses towards Dengue Virus Infection, 2nd Conference on Impedance-Based Cellular Assays, 21/08/2013 to 23/08/2013, Universit t Regensburg (International)
  • Blood-Brain Barrier Responses to African Trypanosome Infection, 2nd Conference on Impedance-Based Cellular Assays , 21/08/2013 to 23/08/2013, Semmelweis University (International)
  • Inhibitory Potential of Malaysian Medicinal Plant (Phyllanthus) Against Dengue Virus Type 2 (DENV2), National Postgraduate Seminar (NPS2012), 14/06/2012 to 15/06/2012, Institute of Graduate Studies, University of Malaya (University)
  • Phyllanthus spp. as potent antiviral agent against Dengue viruses, 4th Asian Regional Dengue Research Network Meeting, DUKE-NUS Emerging Infectious Diseases Inauguration Symposium, 08/12/2009 to 11/12/2009, Duke-NUS Graduate Medical School Singapore  (International)
ENDOWMENT/GIFT & DONATION
(Contribution Details),(Donor/Contributor),(Type),(Category)
  • Anticancer evaluation of RetroMad1 peptides, Biovalence Sdn Bhd, Research Materials (Gift)
  • Anticancer evaluation of semi-synthetic natural compounds from University of Duhok , University of Duhok, Research Materials (Gift)
AWARDS AND STEWARDSHIP
(Name of Award/Stewardship),(Award Category),(Awarding Institution),(Year Awarded),(Type of Award)
  • International Cancer Foundation Registration Scholarship, Conference, International Cancer Foundation (ICF), 2022 (Scholarship)
  • Malaysia Toray Science Foundation - Science & Technology Research Grant (STRG), Special, Toray Science Foundation, 2021 (Fellowship)
  • MAKNA Cancer Research Award (MRCA) 2021, Special, National Cancer Council, 2021 (Fellowship)
  • Best Presenter for Poster Presentation in the "ASIAN CONFERENCE ON BIOMEDICAL RESEARCH AND LABORATORY MEDICINE", Conference, Malaysian Association of Clinical Biochemists (MACB) , 2021 (Best Presentation)
  • REGISTRATION GRANT AWARD, Conference, European Society for Medical Oncology (ESMO), 2021 (REGISTRATION GRANT )
  • Best Poster Presentation, Conference, Malaysian Society of Biochemistry and Molecular Biology (MSBMB), 2020 (Best Poster Award)
  • International e-Learning Carnival & Conference 2019 UTeM (eLCC) , Competition, Universiti Teknikal Malaysia Melaka (UTEM), 2019 (Gold)
  • KSBMB International Conference 2019, Conference, Korean Society for Biochemistry and Molecular Biology (KSBMB), 2019 (Travel Award)
  • Young Scientist Program, Conference, Korean Society for Biochemistry and Molecular Biology (KSBMB), 2019 (Best Presentation)
  • Transforming Education through Trailblazing Innovations, Education, Monash University Malaysia campus, 2018 (Creativity)
  • Silver Award - Putra InnoCreative Competition 2018, Education, Universiti Putra Malaysia (UPM), 2018 (Creativity)
  • Travel Grant, Education, Hong Kong University, Hong Kong, 2018 (Fellowship)
  • IUBMB YSP Observer Fellowship, Conference, International Union of Biochemistry and Molecular Biology (IUBMB), 2018 (Fellowship)
  • 24th IUBMB-15th FAOBMB Congress (IUBMB Seoul 2018) - Travel Grant, Conference, International Union of Biochemistry and Molecular Biology (IUBMB), 2018 (Fellowship)
  • The Arturo Falaschi ICGEB Fellowships programme: Postdoctoral Fellowship, Education, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy , 2015 (Fellowship)
  • National Science Fellowship, Education, Ministry of Higher Education, 2009 (Fellowship)
ACADEMIC/TECHNICAL CONTRIBUTION
(Activity),(Organisation),(Duration),(Role)
  • Taylor's 11th Teaching and Learning Conference, Taylor's University, 2019 to 2019 (Committee Member)
  • Intervarsity Biochemistry Seminar (IBS) 2018, Malaysian Society of Biochemistry and Molecular Biology, 2018 to 2018 (Advisor)
  • Member of Emergency Response Team (ERT) , Emergency Response Team (ERT) , 2017 to 2021 (member)
CONTRIBUTION TO SOCIETY
(Contribution to Society),(Duration),(Level)
  • Volunteer in "Program Keusahawanan Taylors-CIMB Islamic (PPR Sri Pantai & PPR Kg Limau)", 03/02/2018 to 03/02/2018 (Community)
  • Volunteer in "Program Keusahawanan Taylors-CIMB Islamic (PPR Kg Muhibbah)", 27/01/2018 to 27/01/2018 (Community)
COURSE ATTENDED
(Course Title),(Course Mode),(Date/Duration),(Level)
  • Laboratory Safety Induction Sciences and Chemical Engineering Programmes, Research, 23/01/2019 to 23/01/2019 (University)
  • Let's Integrate Technology into the Classroom, Non research, 17/11/2017 to 17/11/2017 (University)
  • Research Engagement @ Taylor's, Research, 10/11/2017 to 10/11/2017 (University)
  • Be Visible Through Research Expert Management System (REMS) , Research, 27/10/2017 to 27/10/2017 (University)
  • Talk on Malaysian Research Assessment (MyRA) , Research, 27/10/2017 to 27/10/2017 (University)
  • Human Resource Policies, Non research, 27/10/2017 to 27/10/2017 (University)
  • Taylor's Graduate Capabilities, Non research, 25/10/2017 to 25/10/2017 (University)
  • Managing & Appreciating Leaner's Diversity, Non research, 23/10/2017 to 23/10/2017 (University)
  • Academic Policies & Procedures (Part 2), Non research, 11/10/2017 to 11/10/2017 (University)
  • Academic Policies & Procedures (Part 1), Non research, 09/10/2017 to 09/10/2017 (University)
  • Teaching & Learning Support @ Intellect and Information Exploration, Non research, 06/10/2017 to 06/10/2017 (University)
  • TEG & University Induction, Non research, 06/10/2017 to 06/10/2017 (University)
  • SBS Sharing Session: Innovative Assessment Strategies and Tools , Non research, 04/10/2017 to 04/10/2017 (Department/School)
  • Maximising Learning through Collaborative Classroom (X-Space) , Non research, 20/09/2017 to 20/09/2017 (University)
  • Your TIMES Begins, Non research, 19/09/2017 to 19/09/2017 (University)
  • Taylor's Teaching & Learning Framework, Research, 19/09/2017 to 19/09/2017 (University)
  • Building Trust Incrementally , Non research, 23/08/2017 to 23/08/2017 (University)
  • Successful Delegation: Supervise and Encourage , Research, 23/08/2017 to 23/08/2017 (University)
  • Choosing the Right Team Culture , Non research, 23/08/2017 to 23/08/2017 (University)
  • Basic and Clinical Immunology Course 2013, Research, 23/07/2013 to 27/07/2013 (International)